These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21412582)

  • 1. Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients.
    Brites C; Goyanna F; França LG; Pedroso C; Netto EM; Adriano S; Sampaio J; Harrington W
    Braz J Infect Dis; 2011; 15(1):6-11. PubMed ID: 21412582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
    Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.
    Visconti A; Visconti L; Bellocco R; Binkin N; Colucci G; Vernocchi L; Amendola M; Ciaci D
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1228-37. PubMed ID: 7901382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing problems in diagnosing HTLV infection among intravenous drug users with AIDS in São Paulo City, Brazil.
    Casseb J; Souza T; Pierre-Lima MT; Yeh E; Hendry RM; Gallo D
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1639-41. PubMed ID: 9430256
    [No Abstract]   [Full Text] [Related]  

  • 6. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
    Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2.
    Zehender G; Colasante C; Santambrogio S; De Maddalena C; Massetto B; Cavalli B; Jacchetti G; Fasan M; Adorni F; Osio M; Moroni M; Galli M
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):440-7. PubMed ID: 12447016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count.
    Regis C; Oliveira A; Brites C
    Braz J Infect Dis; 2009 Aug; 13(4):311-3. PubMed ID: 20231997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
    Oo Z; Barrios CS; Castillo L; Beilke MA
    J Med Virol; 2015 May; 87(5):790-7. PubMed ID: 25678365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Laboratory Outcomes in HIV-1 and HTLV-1/2 Coinfection: A Systematic Review.
    Montaño-Castellón I; Marconi CSC; Saffe C; Brites C
    Front Public Health; 2022; 10():820727. PubMed ID: 35359787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HTLV-I and HTLV-II infections among HIV-1-infected asymptomatic individuals in São Paulo, Brazil.
    Casseb J; Caterino-de-Araujo A; Hong MA; Salomão S; Gallo D; Hendry RM; Duarte AJ
    Rev Inst Med Trop Sao Paulo; 1997; 39(4):213-5. PubMed ID: 9640784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients.
    Norrgren H; Bamba S; Da Silva ZJ; Koivula T; Andersson S
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e142-7. PubMed ID: 20395161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
    Hershow RC; Galai N; Fukuda K; Graber J; Vlahov D; Rezza G; Klein RS; Des Jarlais DC; Vitek C; Khabbaz R; Freels S; Zuckerman R; Pezzotti P; Kaplan JE
    J Infect Dis; 1996 Aug; 174(2):309-17. PubMed ID: 8699060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB; Lai SH; Chitwood DD; Klimas NG; Smith PC; Fletcher MA
    Lancet; 1990 Jun; 335(8703):1439-41. PubMed ID: 1972217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evidence of HTLV-I and HTLV-II coinfections in HIV-1 positive patients in Belém, state of Pará, Brazil.
    Vallinoto AC; Azevedo VN; Santos DE; Caniceiro S; Mesquita FC; Hall WW; Ishak MO; Ishak R
    Mem Inst Oswaldo Cruz; 1998; 93(3):407-9. PubMed ID: 9698879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of retroviral infections on immune function in African-American intravenous drug users.
    Klimas NG; Page JB; Patarca R; Chitwood D; Morgan R; Fletcher MA
    AIDS; 1993 Mar; 7(3):331-5. PubMed ID: 8471194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.